Wellcome Foundation Ltd v VR Laboratories (Aust) Pty Ltd

Link copied
Case Copied 39 min read

HIGH COURT OF AUSTRALIA

Gibbs A.C.J., Stephen, Mason, Aickin and Wilson JJ.

WELLCOME FOUNDATION LTD. v. V.R. LABORATORIES (AUST.) PTY. LTD.

(1981) 148 CLR 262

13 March 1981

Patents

Patents—Practice—Discovery—Issue of obviousness—Relevance of inventor's experiments and research.

Decisions


1981, March 13.
The following written judgments were delivered: -
GIBBS J. I have had the advantage of reading the reasons for judgment prepared by my brother Aickin and am in agreement with them. I would accordingly dismiss the appeal. (at p268)

STEPHEN J. I agree that, for the reasons given by Aickin J., this appeal should be dismissed. (at p268)

MASON J. I agree that the appeal should be dismissed for the reasons given by Aickin J. (at p268)

AICKIN J. This is an appeal by special leave from the Full Court of the Federal Court of Australia which dismissed an appeal from a decision of Rath J. in the Supreme Court of New South Wales. Rath J. had ordered that the appellant (the holder of Australian letters patent) should file and serve a further and better affidavit of discovery in a patent action in which it had sued the respondent for infringement of Australian Patent No. 459109 for "improvements in or relating to injectable therapeutic compositions." The respondent denied infringement and counterclaimed for a declaration of invalidity. The particulars of the grounds of invalidity were that the patent specification did not comply with s. 40 of the Patents Act 1952 (Cth), as amended, ("the Act"), that the invention claimed was not an invention within the meaning of the Act, that the invention was obvious and did not involve an inventive step having regard to what was known or used in Australia on or before the priority date of each claim, and that the invention was not novel in Australia on the priority date of each claim. The respondent failed to give any particulars of its contention that the invention was obvious, as required by ss. 117 and 166 of the Act, but did give particulars as to want of novelty. However no step in the proceeding was taken to enforce the obligation to give particulars of obviousness, limited though they may generally be. (at p269)

2. The appellant gave discovery but the respondent sought an order for further discovery to include documents of the following classes - (a) documents relating to research and development and experimental work on the claimed invention both before and after the priority date of the subject letters patent; (b) documents relating to the provisional application for the patent and documents relating to the application for the complete patent, as the case may be, both in the United Kingdom and in Australia and elsewhere insofar as they contain matters relevant to (a), and in any event, all such documents for the United Kingdom and Australia; (c) documents relating to infringement, revocation or opposition proceedings in any country of the world which a corresponding patent has issued or been applied for, in so far as they contain…
CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read Wellcome Foundation Ltd v VR Laboratories (Aust) Pty Ltd and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[1981] HCA 12
Decision Date

CaseChat Overview and Summary

The Full Court of the High Court of Australia heard an appeal from a decision of the Supreme Court of Victoria concerning the validity of a patent for a new pharmaceutical compound. The appellant, Wellcome Foundation Ltd, was the patentee, and the respondent, VR Laboratories (Aust) Pty Ltd, was alleged to have infringed the patent. The dispute centred on whether the patent was validly granted, particularly in relation to the novelty and inventiveness of the claimed compound.

The primary legal issues before the High Court were whether the patent sufficiently disclosed the invention, whether the invention was novel at the time of the patent application, and whether the invention involved an inventive step. Specifically, the court had to consider whether the prior art, including earlier publications and existing knowledge, anticipated the claimed compound or rendered its invention obvious to a person skilled in the relevant field. The interpretation of the patent claims and the scope of the monopoly granted were also central to the determination.

The High Court ultimately found that the patent was invalid. The majority reasoned that the patent failed to adequately describe the invention, particularly in relation to the specific compound claimed. They held that the prior art disclosed compounds that were sufficiently similar to the claimed invention, and that the invention did not represent a sufficient inventive step over that prior art. The court applied the principles of patent law concerning the requirements for novelty, inventive step, and sufficient disclosure, emphasizing the need for a patent to clearly define the invention and demonstrate a genuine advance in the field.

Orders

Orders of the court

Full text does not contain this section.

Background

Background to the litigation

Full text does not contain this section.

Evidence

Evidence Before The Court

Full text does not contain this section.

Decision

Reasons for decision

Full text does not contain this section.

Ratio Decidendi

Legal Principle Established

Full text does not contain this section.